| The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. R Ferracini, MF Di Renzo, K Scotlandi, N Baldini, M Olivero, P Lollini, ... Oncogene 10 (4), 739-749, 1995 | 378 | 1995 |
| CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib R Piva, B Ruggeri, M Williams, G Costa, I Tamagno, D Ferrero, V Giai, ... Blood, The Journal of the American Society of Hematology 111 (5), 2765-2775, 2008 | 333 | 2008 |
| The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation L Naldini, E Vigna, R Ferracini, P Longati, L Gandino, M Prat, ... Molecular and cellular biology, 1991 | 227 | 1991 |
| Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase. R Ferracini, P Longati, L Naldini, E Vigna, PM Comoglio Journal of Biological Chemistry 266 (29), 19558-19564, 1991 | 185 | 1991 |
| MET Overexpression Turns Human Primary Osteoblasts into Osteosarcomas S Patane, S Avnet, N Coltella, B Costa, S Sponza, M Olivero, E Vigna, ... Cancer research 66 (9), 4750-4757, 2006 | 164 | 2006 |
| Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. R Ferracini, M Olivero, MF Di Renzo, M Martano, C De Giovanni, P Nanni, ... Oncogene 12 (8), 1697-1705, 1996 | 147 | 1996 |
| Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement I Roato, M Grano, G Brunetti, S Colucci, A Mussa, O Bertetto, R Ferracini The FASEB journal 19 (2), 1-24, 2005 | 119 | 2005 |
| PMMA-based bone cements and the problem of joint arthroplasty infections: status and new perspectives A Bistolfi, R Ferracini, C Albanese, E Vernè, M Miola Materials 12 (23), 4002, 2019 | 106 | 2019 |
| Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM− Lung Cancer–Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis G Bertolini, L D'Amico, M Moro, E Landoni, P Perego, R Miceli, L Gatti, ... Cancer research 75 (17), 3636-3649, 2015 | 105 | 2015 |
| Osteoclasts are active in bone forming metastases of prostate cancer patients I Roato, P D’Amelio, E Gorassini, A Grimaldi, L Bonello, C Fiori, ... PloS one 3 (11), e3627, 2008 | 104 | 2008 |
| Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma N Coltella, MC Manara, V Cerisano, L Trusolino, MF Di Renzo, ... The FASEB Journal 17 (9), 1162-1164, 2003 | 99 | 2003 |
| p145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line S Giordano, MF Di Renzo, R Ferracini, L Chiadò-Piat, PM Comoglio Molecular and cellular biology, 1988 | 98 | 1988 |
| A cell surface integral membrane glycoprotein of 85,000 mol wt (gp85) associated with triton X-100-insoluble cell skeleton. G Tarone, R Ferracini, G Galetto, P Comoglio The Journal of cell biology 99 (2), 512-519, 1984 | 95 | 1984 |
| Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors. K Scotlandi, N Baldini, M Oliviero, MF Di Renzo, M Martano, M Serra, ... The American journal of pathology 149 (4), 1209, 1996 | 93 | 1996 |
| Bone allografts and adjuvant cisplatin for the treatment of canine appendicular osteosarcoma in 18 dogs E Morello, P Buracco, M Martano, B Peirone, C Capurro, A Valazza, ... Journal of Small Animal Practice 42 (2), 61-66, 2001 | 86 | 2001 |
| Scaffolds as structural tools for bone-targeted drug delivery R Ferracini, I Martínez Herreros, A Russo, T Casalini, F Rossi, G Perale Pharmaceutics 10 (3), 122, 2018 | 82 | 2018 |
| Concentrated adipose tissue infusion for the treatment of knee osteoarthritis: clinical and histological observations I Roato, DC Belisario, M Compagno, A Lena, A Bistolfi, L Maccari, ... International Orthopaedics 43, 15-23, 2019 | 79 | 2019 |
| IL-7 up-regulates TNF-α-dependent osteoclastogenesis in patients affected by solid tumor I Roato, G Brunetti, E Gorassini, M Grano, S Colucci, L Bonello, L Buffoni, ... PLoS One 1 (1), e124, 2006 | 78 | 2006 |
| Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma B Castella, M Foglietta, P Sciancalepore, M Rigoni, M Coscia, V Griggio, ... Oncoimmunology 4 (11), e1047580, 2015 | 77 | 2015 |
| Intracellular calcium regulates the tyrosine kinase receptor encoded by the MET oncogene L Gandino, L Munaron, L Naldini, R Ferracini, M Magni, PM Comoglio Journal of Biological Chemistry 266 (24), 16098-16104, 1991 | 73 | 1991 |